Fused amino pyrimidine compounds for treatment of neurodegenerative disorders
US-2026048063-A1 · Feb 19, 2026 · US
Ovid Therapeutics Inc holds 178 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 178 |
| Recent patents | 40 |
| First publication | Nov 5, 2015 |
| Latest publication | Feb 19, 2026 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-2026048063-A1 · Feb 19, 2026 · US
US-2026048062-A1 · Feb 19, 2026 · US
US-12465597-B2 · Nov 11, 2025 · US
US-2025281500-A1 · Sep 11, 2025 · US
US-2025281498-A1 · Sep 11, 2025 · US
Representative or frequently cited publications from precomputed assignee stats.
US-2026048063-A1 · Feb 19, 2026 · US
US-2026048062-A1 · Feb 19, 2026 · US
US-12465597-B2 · Nov 11, 2025 · US
US-2025281500-A1 · Sep 11, 2025 · US
US-2025281498-A1 · Sep 11, 2025 · US
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| A61K31/437 | 97 |
| A61P25/00 | 69 |
| A61K9/0019 | 58 |
| A61K45/06 | 53 |
| A61P25/08 | 53 |
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 175 |
| Chemistry & Metallurgy | 23 |
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.